Clinical Trials - Baltimore

• ACTIV-2/A5401: Adaptive Platform Treatment for Outpatients with COVID-19 (Adapt Out COVID)

  Study Location: BaltimoreIndia

  Eligibility: Adults

  Enrollment: Open

  Read More

• P2026: Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs during Pregnancy and Postpartum

  Study Location: BaltimoreIndia

  Eligibility: Preg/postpartum women. Infants

  Enrollment: Open

  Read More

• Impact of Tuberculosis Infection on HIV-1 Antibody Response (NWCS501)

  Study Location: BaltimoreIndia

  Eligibility: Adults, adolescents

  Enrollment: Open

  Read More

• A5361s: Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE) A5361s: Substudy of REPRIEVE (A5332) Pitavastatin to REduce Physical Function Impairment and FRailty in HIV (PREPARE)

  Study Location: Baltimore

  Eligibility: HIV infected men and women between the ages of 40 and 75 Co-enrolled in REPRIEVE and the Mechanistic (CT) substudy Taking...

  Enrollment: Closed

  Read More

• HPTN083: A Phase 2b/3 Double Blind Safety and Efficacy Study of Injectable Cabotegravir . . . A Phase 2b/3 Double Blind Safety and Efficacy Study of Injectable Cabotegravir Compared to Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine (TDF/FTC), for Pre-Exposure Prophylaxis in HIV-Uninfected Cisgender Men and Transgender Women who have Sex with Men

  Study Location: Baltimore

  Eligibility: HPTN 083 will enroll approximately 4500 HIV-uninfected MSM and TGW at risk for acquiring HIV infection, ages 18 or older at...

  Enrollment: Closed

  Read More

• HPTN 078: Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected MSM Enhancing Recruitment, Linkage to Care and Treatment for HIV-Infected MSM in the United States

  Study Location: Baltimore

  Eligibility: Ages Eligible for Study:   16 Years and older Genders Eligible for Study:   Male Accepts Healthy Volunteers:  ...

  Enrollment: Closed

  Read More

• A5128: Consent for Use of Stored Patient Specimens for Future Testing

  Study Location: Baltimore

  Eligibility: Genders Eligible for Study:   Both Accepts Healthy Volunteers:   Yes Sampling Method:   Non-Probability Sample...

  Enrollment: Open

  Read More

• A5342: Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody Evaluating the Safety, Tolerability, and Effect of a Human Monoclonal Antibody (VRC01) on Markers of HIV Persistence in HIV-Infected Adults Receiving Antiretroviral Therapy (ART)

  Study Location: Baltimore

  Eligibility: Ages Eligible for Study:   18 Years to 65 Years Genders Eligible for Study:   Both Accepts Healthy Volunteers:  ...

  Enrollment: Closed

  Read More

• A5332: Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)

  Study Location: BaltimoreIndia

  Eligibility: HIV infected men and women between the ages of 40 and 75 On HIV medications for at least 6 months CD4 cell count greater...

  Enrollment: Closed

  Read More

• A5329: Interferon –Free Therapy for Chronic Hepatitis C Virus Genotype 1 infection in persons with HIV-1 Coinfection Receiving Concurrent Antiretroviral Therapy: A5334s Pharmacokinetic Substudy

  Study Location: Baltimore

  Eligibility: HIV and Hepatitis C co-infected people 18 to 70 years old HIV viral load less than 50 copies Currently on one of the...

  Enrollment: Closed

  Read More

• HPTN 069: A Phase II Randomized, Double-Blind, Study of the Safety and Tolerability of Maraviroc (MVC), Maraviroc + Emtricitabine (MVC+FTC), Maraviroc + Tenofovir disoproxil fumarate (MVC+TDF)

  Study Location: Baltimore

  Eligibility: HIV-uninfected at-risk MSM and at-risk women > 18 years.

  Enrollment: Closed

  Read More

• A5327: Sofosbuvir + Ribavirin w/o Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals (SWIFT-C)

  Study Location: Baltimore

  Eligibility: Men and women > 18 years, HIV+ and currently on stable antiretroviral (ARV) medications or on for at least 8 weeks and be...

  Enrollment: Closed

  Read More

• A5322: Long-Term Follow-up of Older HIV-infected Adults in the ACTG: Addressing Issues of Aging, HIV Infection and Inflammation – HAILO

  Study Location: Baltimore

  Eligibility: Participants actively followed in the ALLRT (A5001) at the time of enrollment into A5322 or completed follow-up in ALLRT (A5001)...

  Enrollment: Closed

  Read More

• A5324: A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification with Maraviroc and Dolutegravir with No Intensification or Intensification with Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV

  Study Location: Baltimore

  Eligibility: Men and women > 18 years old who have HIV-associated neurocognitive disorder (HAND) as defined by the Frascati...

  Enrollment: Open

  Read More

• A5320: Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)

  Study Location: Baltimore

  Eligibility: Men and women ≥ 18 years old, HCV/HIV-1 coinfected who failed HCV therapy any time after HCV/DAA treatment discontinuation...

  Enrollment: Closed

  Read More

• A5314: Effect of LDMTX on Inflammation in HIV-infected Individuals

  Study Location: Baltimore

  Eligibility: HIV-infected men and women ≥40 years old, who have been virologically suppressed on continuous antiretroviral therapy for at...

  Enrollment: Closed

  Read More